Hannah Whipple-Macedo, a Senior Program Manager Consultant with a focus on drug development, has been featured in the Influential Women for Impact in Biotech and Pharma program. With over a decade of experience, she has played a crucial role in supporting biotechnology and pharmaceutical teams throughout the complex execution of their projects. Whipple-Macedo has worked…more
The Jefferson County Economic Development Corporation (Jeffco EDC) has announced the winners of the 2025 Gateways Awards, recognizing the individuals, initiatives, and collaborations shaping the area’s economic landscape. The awards ceremony took place at the Social Capitol Events Center in Arvada, bringing together over 300 leaders from business, civic, and community sectors. “The Gateways shine…more
PharmaJet has signed a Distribution Agreement with ATR, an affiliate of EVA Pharma, aimed at enhancing access to needle-free vaccinations in Egypt and the broader region. The agreement was finalized on October 30, 2025, during the CPHI meeting in Frankfurt. It includes arrangements for the distribution, technology transfer, and manufacturing of PharmaJet’s needle-free injection technology.…more
Aclarion, Inc., a healthcare technology company focused on chronic low back pain, has appointed Dan Isherwood as its UK Commercial Director. This marks Aclarion’s first dedicated commercial sales hire and highlights the company’s strategy to expand its market presence in the UK. The UK has become Aclarion’s first market where physicians can order its Nociscan…more
Jefferson County Economic Development Corporation (Jeffco EDC) has announced the finalists for the 4th annual Gateways Awards, honoring individuals and initiatives that contribute to economic vitality and community impact across Jefferson County. The awards will be presented on Wednesday, November 5, at the Social Capitol Event Venue in Arvada. Presented by JE Dunn Construction, the…more
PharmaJet has announced that its needle-free injection technology will be utilized in an upcoming polio immunization campaign in Pakistan scheduled for late 2025. This initiative comes as part of Pakistan’s expanded vaccination drive targeting children up to age 15, in response to a resurgence of polio cases in the country. The campaign, which will take…more
The 2025 list of manufacturers based in Jefferson County has been released, showcasing a total of 102 companies ranked by their number of employees. The top three employers are Trimble, Ball Corp., and CoorsTek, with employee counts of 4,727, 4,616, and 2,437, respectively. The industry breakdown among the top 49 companies indicates a strong presence…more
The Blood Center in New Orleans has implemented Terumo Blood and Cell Technologies’ FDA-cleared automation technology to enhance platelet processing, becoming the second blood center in the U.S. to do so. This development aims to address ongoing platelet shortages and improve the efficiency of blood collection operations. The Reveos automation system from Terumo BCT is…more
Terumo Blood and Cell Technologies (Terumo BCT) is collaborating with Hemex Health to improve diagnosis and treatment for millions affected by sickle cell disease and other hemoglobin disorders. This partnership follows Terumo’s minority investment in Hemex Health and the appointment of Chetan Makam to Hemex’s Board of Directors. The collaboration aims to enhance access to…more
PharmaJet Inc. is expanding its needle-free injection technology by developing self-injection pens designed for home use. These pens will allow for precise administration of various pharmaceuticals without the need for traditional needles. The injectors are targeted at chronic disease and metabolic peptide markets and are currently undergoing early testing. By offering a needle-free option, PharmaJet…more
Kenya, Uganda, and Côte d’Ivoire have entered into a significant partnership with Terumo Blood and Cell Technologies to develop national frameworks for addressing sickle cell disease (SCD). This collaboration aims to tackle one of the most pressing public health challenges in Africa, where SCD accounts for a high rate of child mortality. The agreement, formalized…more
Aclarion Inc. has enrolled its first two patients at the UHealth – University of Miami Health System in its pivotal CLARITY trial. This randomized study is set to evaluate the ability of Nociscan to improve surgical outcomes for patients suffering from chronic low back pain. The CLARITY trial aims to assess the clinical and economic…more